# Fueling or Fighting Cancer? The Thermogenic Paradox of Brown Adipose Tissue

**Authors:** Jonathan Jaime G. Guerrero, Paolo C. Encarnacion, Chih-Hao Wang, Mark Angelo S. del Rosario, Kin Israel Notarte, Jiayan Zhou, Yi-Ta Hsieh, Wan-Yu Wang, Ching-Wen Chang, Wan-Chun Li

PMC · DOI: 10.1007/s13679-026-00699-3 · 2026-03-18

## TL;DR

Brown fat can both protect against and worsen cancer, depending on the context, highlighting its complex role in metabolism and disease.

## Contribution

This review introduces the 'thermogenic paradox' of brown adipose tissue in cancer, revealing its dual role in protection and progression.

## Key findings

- Adaptive browning reduces metabolic inflammation and may suppress tumors.
- Tumor-induced thermogenesis contributes to cancer cachexia via UCP1 and β3-adrenergic signaling.
- BAT's effects on cancer depend on regulatory pathways and context.

## Abstract

The global rise in obesity and metabolic syndrome has intensified interest in brown adipose tissue (BAT) as a regulator of energy metabolism and potential modulator of cancer risk. BAT-mediated thermogenesis and the browning of white adipose tissue (WAT) confer metabolic benefits that may reduce oncogenic susceptibility. However, emerging evidence reveals a paradoxical role for BAT in cancer progression, where tumor-induced thermogenic activation contributes to cancer-associated cachexia (CAC). This review article examines the cellular, molecular, and translational dimensions of this “thermogenic paradox”.

A narrative synthesis was performed using literature from 2000 to 2025 retrieved from PubMed, Scopus, Web of Science, and Google Scholar. Peer-reviewed studies examining the molecular, genetic, and metabolic mechanisms linking BAT or adipose browning to carcinogenesis, obesity-related cancers, and CAC were included. Thematic integration emphasized regulatory pathways, endocrine signaling, and therapeutic implications. Adaptive browning, regulated by transcriptional drivers such as PRDM16, PPARγ, and PGC1-α, mitigates metabolic inflammation, enhances insulin sensitivity, and may exert tumor-suppressive effects. In contrast, tumor-secreted factors including parathyroid hormone-related protein (PTHrP) and interleukin-6 aberrantly induce uncoupling protein 1 (UCP1) expression and β3-adrenergic signaling, driving lipolysis and energy wasting in CAC. The dualistic effects of BAT underscore its context-dependent influence on cancer biology.

BAT exemplifies a metabolic continuum between protection and pathology. Clarifying its regulatory mechanisms may inform precision therapies and integrated metabolic-oncology interventions, particularly relevant to low- and middle-income countries facing the double burden of obesity and cachexia.

## Linked entities

- **Genes:** PRDM16 (PR/SET domain 16) [NCBI Gene 63976], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], UCP1 (uncoupling protein 1) [NCBI Gene 7350]
- **Proteins:** IL6 (interleukin 6)
- **Diseases:** obesity (MONDO:0011122), metabolic syndrome (MONDO:0000816), cancer (MONDO:0004992)

## Full-text entities

- **Genes:** LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, HDAC3 (histone deacetylase 3) [NCBI Gene 8841] {aka HD3, KDAC3, RPD3, RPD3-2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, EWSR1 (EWS RNA binding protein 1) [NCBI Gene 2130] {aka EWS, EWS-FLI1}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Foxp4 (forkhead box P4) [NCBI Gene 74123] {aka 1200010K03Rik, 2310007G05Rik, mFKHLA}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, ESRRA (estrogen related receptor alpha) [NCBI Gene 2101] {aka ERR1, ERRa, ERRalpha, ESRL1, NR3B1}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, MIR27A (microRNA 27a) [NCBI Gene 407018] {aka MIR27, MIRN27A, mir-27a}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068] {aka ALKBH9, BMIQ14, GDFD, IFEX9}, Prdm16 (PR domain containing 16) [NCBI Gene 70673] {aka 5730557K01Rik, csp1, mel1}, MIR27B (microRNA 27b) [NCBI Gene 407019] {aka MIR-27b, MIRN27B, miRNA27B}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, FNDC5 (fibronectin type III domain containing 5) [NCBI Gene 252995] {aka FRCP2, irisin}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, FAT1 (FAT atypical cadherin 1) [NCBI Gene 2195] {aka CDHF7, CDHR8, FAT, ME5, hFat1}, ZNF516 (zinc finger protein 516) [NCBI Gene 9658] {aka HsT287}, RBL1 (RB transcriptional corepressor like 1) [NCBI Gene 5933] {aka CP107, PRB1, p107}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, PRDM16 (PR/SET domain 16) [NCBI Gene 63976] {aka CMD1LL, KMT8F, LVNC8, MEL1, PFM13}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, Adrb3 (adrenergic receptor, beta 3) [NCBI Gene 11556] {aka Adrb-3, beta 3-AR}, IRX3 (iroquois homeobox 3) [NCBI Gene 79191] {aka IRX-1, IRXB1}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, SLC25A19 (solute carrier family 25 member 19) [NCBI Gene 60386] {aka DNC, MCPHA, MTPPT, MUP1, THMD3, THMD4}, Ctbp1 (C-terminal binding protein 1) [NCBI Gene 13016] {aka BARS, CtBP3/BARS, D4S115h, D5H4S115, D5H4S115E}, BMP8B (bone morphogenetic protein 8b) [NCBI Gene 656] {aka BMP8, OP2}, SRRM2 (serine/arginine repetitive matrix 2) [NCBI Gene 23524] {aka 300-KD, CWF21, Cwc21, HSPC075, MRD72, SRL300}, WNT10B (Wnt family member 10B) [NCBI Gene 7480] {aka SHFM6, STHAG8, WNT-12}, FGF21 (fibroblast growth factor 21) [NCBI Gene 26291], NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, STAT5A (signal transducer and activator of transcription 5A) [NCBI Gene 6776] {aka MGF, STAT5}, MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}, BMP7 (bone morphogenetic protein 7) [NCBI Gene 655] {aka OP-1}, BAAT (bile acid-CoA:amino acid N-acyltransferase) [NCBI Gene 570] {aka BACAT, BACD1, BAT, FHCA3, HCHO}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}, EBF2 (EBF transcription factor 2) [NCBI Gene 64641] {aka COE2, EBF-2, O/E-3, OE-3}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442] {aka VR1}, Bfar (bifunctional apoptosis regulator) [NCBI Gene 67118] {aka 3010001A07Rik, 3110001I22Rik, Bar, Rnf47}, PLAC8 (placenta associated 8) [NCBI Gene 51316] {aka C15, DGIC, PNAS-144, onzin}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, FGF6 (fibroblast growth factor 6) [NCBI Gene 2251] {aka HBGF-6, HST2}, KDM3A (lysine demethylase 3A) [NCBI Gene 55818] {aka JHDM2A, JHMD2A, JMJD1, JMJD1A, TSGA}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, MEF2A (myocyte enhancer factor 2A) [NCBI Gene 4205] {aka ADCAD1, RSRFC4, RSRFC9, mef2}, HSPA9 (heat shock protein family A (Hsp70) member 9) [NCBI Gene 3313] {aka CRP40, CSA, EVPLS, GRP-75, GRP75, HEL-S-124m}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, MSTN (myostatin) [NCBI Gene 2660] {aka GDF8, MSLHP}, Ucp1 (uncoupling protein 1 (mitochondrial, proton carrier)) [NCBI Gene 22227] {aka Slc25a7, Ucp}, LEPR (leptin receptor) [NCBI Gene 3953] {aka CD295, LEP-R, LEPRD, OB-R, OBR, huB219}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, SLC25A6 (solute carrier family 25 member 6) [NCBI Gene 293] {aka AAC3, ANT, ANT 2, ANT 3, ANT3, ANT3Y}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, PPARGC1B (PPARG coactivator 1 beta) [NCBI Gene 133522] {aka ERRL1, PERC, PGC-1(beta), PGC1B}
- **Diseases:** Resistance (MESH:D060467), Cachexia (MESH:D002100), oncological (MESH:D000072716), diabetes (MESH:D003920), colon cancer (MESH:D015179), tumorigenic (MESH:D002471), liver cancer (MESH:D006528), cardiovascular disorders (MESH:D002318), non-small-cell lung cancer (MESH:D002289), deaths (MESH:D003643), malnutrition (MESH:D044342), carcinogenesis (MESH:D063646), Obesity (MESH:D009765), atrophy (MESH:D001284), insulin resistance (MESH:D007333), hypermetabolism (MESH:C565498), adiposity (MESH:D018205), inflammation (MESH:D007249), carcinogenic (MESH:D011230), lean mass loss (MESH:D013851), metabolic syndrome (MESH:D024821), breast cancer (MESH:D001943), fibrosis (MESH:D005355), tissue loss (MESH:D017695), weight loss (MESH:D015431), CAC (MESH:D009369), chronic (MESH:D002908), wasting (MESH:D019282), overweight (MESH:D050177), Metabolic dysfunction (MESH:D008659), NCDs (MESH:D000073296), fat and muscle loss (MESH:D009135), hyperlipidemia (MESH:D006949)
- **Chemicals:** lipid (MESH:D008055), Norepinephrine (MESH:D009638), triacylglycerol (MESH:D014280), malonyl-CoA (MESH:D008316), capsaicin (MESH:D002211), iron (MESH:D007501), resveratrol (MESH:D000077185), catecholamine (MESH:D002395), TCA (MESH:D014233), cGMP (MESH:D006152), FDG (MESH:D019788), fatty acid (MESH:D005227), B3-adrenergic agents (-), NO (MESH:D009569), thyroxine (MESH:D013974), glucose (MESH:D005947), withanone (MESH:C560597), free fatty acids (MESH:D005230), ATP (MESH:D000255), proton (MESH:D011522)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12999789/full.md

---
Source: https://tomesphere.com/paper/PMC12999789